BIO-Europe® 2016: Cinfa outlines biosimilar development areas and deal opportunities

November 22, 2016
Cinfa Biotech's managing director, Ruediger Jankowsky, chats with Mike Ward, global director of content for Informa Pharma Intelligence, about the company's founding and focus on biosimilar drug development. They discuss Cinfa's biosimilars business model, disease areas of focus and potential deals for the company in the near future.
Previous Video
BIO-Europe® 2016: Freshly-appointed Auspherix CEO highlights new antibiotic class
BIO-Europe® 2016: Freshly-appointed Auspherix CEO highlights new antibiotic class

Dr. Neil Miller, the recently-appointed CEO of UK-based biotech, Auspherix, talks to Scrip about the compan...

Next Video
BIO-Europe® 2016: eTheRNA CEO outlines development plan in cancer RNA space
BIO-Europe® 2016: eTheRNA CEO outlines development plan in cancer RNA space

Mike Ward, global director of content for Informa Pharma Intelligence, interviews Dirk Reyn, CEO of eTheRNA...